Sign in
4

Changes in Ownership

AIM ImmunoTech Inc. Filed Acc 0001613377-17-000032

Options or other derivatives

  • Director acquired 25,284 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Appelrouth Stewart · Director

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2017-07-31 Grant or award : show line 1 in the form Options to buy Common Stock +25,284 $0.30 $7,585 25,284 D
Loading xslF345X03/primary_doc.xml…